一、英文文章：

1.         Chen W, Wang JB, Abnet CC, Dawsey SM, Fan JH, Yin LY, Yin J, Taylor PR, Qiao YL, Freedman ND. Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015, 24(2):386-392. doi: 10.1158/1055-9965.Epi-14-1038.

2.         Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Barnett MJ, Goodman GE, Smith JS, Qiao YL et al. Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study. Cancer causes & control : CCC. 2015, 26(12):1835-1844. doi: 10.1007/s10552-015-0676-3.

3.         Huang H, Hu XF, Zhao FH, Garland SM, Bhatla N, Qiao YL. Estimation of Cancer Burden Attributable to Infection in Asia. Journal of epidemiology. 2015, 25(10):626-638. doi: 10.2188/jea.JE20140215.

4.         Jeronimo J, Bansil P, Valdez M, Kang LN, Zhao FH, Qiao YL, Chen W, Zhang X, Paul P, Bai P et al. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer. Journal of lower genital tract disease. 2015, 19(3):220-223. doi: 10.1097/lgt.0000000000000088.

5.         Levin C, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ. An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China. In: Cancer: Disease Control Priorities, Third Edition (Volume 3). Edited by Gelband H, Jha P, Sankaranarayanan R, Horton S. Washington (DC): The International Bank for Reconstruction and Development / The World Bank © 2015 International Bank for Reconstruction and Development / The World Bank.; 2015. doi: 10.1596/978-1-4648-0349-9_ch18.

6.         Li J, Kang LN, Li B, Pang Y, Huang R, Qiao YL. Effect of a group educational intervention on rural Chinese women's knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines. BMC cancer. 2015, 15:691. doi: 10.1186/s12885-015-1682-2.

7.         Liao GD, Kang LN, Chen W, Zhang X, Liu XY, Zhao FH, Stoler MH, Mills A, Xi MR, Qiao YL et al. p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer. Journal of lower genital tract disease. 2015, 19(3):207-211. doi: 10.1097/lgt.0000000000000080.

8.         Lin CQ, Cui JF, Zhang X, Pan QJ, Chen W, Qiao YL. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China. Acta cytologica. 2015, 59(5):405-411. doi: 10.1159/000441290.

9.         Lin SW, Freedman ND, Shi J, Gail MH, Vogtmann E, Yu G, Klepac-Ceraj V, Paster BJ, Dye BA, Wang GQ et al. Beta-diversity metrics of the upper digestive tract microbiome are associated with body mass index. Obesity (Silver Spring, Md). 2015, 23(4):862-869. doi: 10.1002/oby.21020.

10.        Liu Y, Fan JH, Gao X, Ma L, Qiao YL, Zhang L. The Natural Progression of Parkinson's Disease in a Small Cohort with 15 Drug-na?ve Patients. Chinese medical journal. 2015, 128(13):1761-1764. doi: 10.4103/0366-6999.159350.

11.        Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A, Brinton LA, Chang IS, Chen C, Chen C et al. Characterization of large structural genetic mosaicism in human autosomes. American journal of human genetics. 2015, 96(3):487-497. doi: 10.1016/j.ajhg.2015.01.011.

12.        Murphy G, Freedman ND, Michel A, Fan JH, Taylor PR, Pawlita M, Qiao YL, Zhang H, Yu K, Abnet CC et al. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort. International journal of cancer. 2015, 137(8):1938-1946. doi: 10.1002/ijc.29543.

13.        Qiao Y. [Screening technologies to advance rapid testing for cervical cancer prevention in developing countries]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2015, 49(2):110-111. doi:

14.        Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 2015, 107(12):djv279. doi: 10.1093/jnci/djv279.

15.        Sankaranarayanan R, Qiao YL, Keita N. The next steps in cervical screening. Women's health (London, England). 2015, 11(2):201-212. doi: 10.2217/whe.14.70.

16.        Sivasubramaniam PG, Zhang BL, Zhang Q, Smith JS, Zhang B, Tang ZH, Chen GJ, Xie XM, Xu XZ, Yang HJ et al. Breast Cancer Disparities: A Multicenter Comparison of Tumor Diagnosis, Characteristics, and Surgical Treatment in China and the U.S. The oncologist. 2015, 20(9):1044-1050. doi: 10.1634/theoncologist.2014-0290.

17.        Song Y, Zhao YQ, Zhang X, Liu XY, Li L, Pan QJ, Shen GH, Zhao FH, Chen F, Chen W et al. Random biopsy in colposcopy-negative quadrant is not effective in women with positive colposcopy in practice. Cancer epidemiology. 2015, 39(2):237-241. doi: 10.1016/j.canep.2015.01.008.

18.        Sung H, Yang HH, Zhang H, Yang Q, Hu N, Tang ZZ, Su H, Wang L, Wang C, Ding T et al. Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers. International journal of epidemiology. 2015, 44(4):1341-1352. doi: 10.1093/ije/dyv050.

19.        Trimble EL, Rajaraman PL, Chao A, Gross T, Levin C, Qiao YL, Rebbeck T, Stevens L, Zhao FH. Need for National Commitments to Cancer Research to Guide Public Health Investment and Practice. In: Cancer: Disease Control Priorities, Third Edition (Volume 3). Edited by Gelband H, Jha P, Sankaranarayanan R, Horton S. Washington (DC): The International Bank for Reconstruction and Development / The World Bank © 2015 International Bank for Reconstruction and Development / The World Bank.; 2015. doi: 10.1596/978-1-4648-0349-9_ch15.

20.        Vogtmann E, Flores R, Yu G, Freedman ND, Shi J, Gail MH, Dye BA, Wang GQ, Klepac-Ceraj V, Paster BJ et al. Association between tobacco use and the upper gastrointestinal microbiome among Chinese men. Cancer causes & control : CCC. 2015, 26(4):581-588. doi: 10.1007/s10552-015-0535-2.

21.        Wang JB, Dawsey SM, Fan JH, Freedman ND, Tang ZZ, Ding T, Hu N, Wang LM, Wang CY, Su Het al. Common genetic variants related to vitamin D status are not associated with esophageal squamous cell carcinoma risk in China. Cancer epidemiology. 2015, 39(2):157-159. doi: 10.1016/j.canep.2014.12.013.

22.        Wang SM, Hu SY, Chen W, Chen F, Zhao FH, He W, Ma XM, Zhang YQ, Wang J, Sivasubramaniam P et al. Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening. BMC cancer. 2015, 15:848. doi: 10.1186/s12885-015-1882-9.

23.        Wang SM, Qiao YL. Implementation of cervical cancer screening and prevention in China--challenges and reality. Japanese journal of clinical oncology. 2015, 45(1):7-11. doi: 10.1093/jjco/hyu188.

24.        Wang SM, Yin LY, Zhang Y, Fan JH, Chang IJ, Dawsey SM, Taylor PR, Abnet CC, Qiao YL. Multivitamin and mineral supplementation is associated with the reduction of fracture risk and hospitalization rate in Chinese adult males: a randomized controlled study. Journal of bone and mineral metabolism. 2015, 33(3):294-302. doi: 10.1007/s00774-014-0589-3.

25.        Wei WQ, Chen ZF, He YT, Feng H, Hou J, Lin DM, Li XQ, Guo CL, Li SS, Wang GQ et al. Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015, 33(17):1951-1957. doi: 10.1200/jco.2014.58.0423.

26.        Wen Y, Pan XF, Huang WZ, Zhao ZM, Wei WQ, Chen F, Lan H, Huang H, Yang CX, Qiao YL. Quality of life for patients with esophageal/gastric cardia precursor lesions or cancer: a one-year prospective study. Asian Pacific journal of cancer prevention : APJCP. 2015, 16(1):45-51. doi: 10.7314/apjcp.2015.16.1.45.

27.        Yu S, Yang CS, Li J, You W, Chen J, Cao Y, Dong Z, Qiao Y. Cancer Prevention Research in China. Cancer prevention research (Philadelphia, Pa). 2015, 8(8):662-674. doi: 10.1158/1940-6207.capr-14-0469.

28.        Zhang BL, Sivasubramaniam PG, Zhang Q, Wang J, Zhang B, Gao JD, Tang ZH, Chen GJ, Xie XM, Wang Z et al. Trends in Radical Surgical Treatment Methods for Breast Malignancies in China: A Multicenter 10-Year Retrospective Study. The oncologist. 2015, 20(9):1036-1043. doi: 10.1634/theoncologist.2014-0281.

29.        Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang ZZ, Li M, Ren ZF, Zheng QQ, Ma W et al. Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China. Annals of epidemiology. 2015, 25(4):231-235. doi: 10.1016/j.annepidem.2014.12.009.

30.        Zhao J, Zhang X, Chen R, Zhao YQ, Wang TT, He S, Qiao YL. Performance of the R-way Colposcopic Evaluation System in Cervical Cancer Screening. Asian Pacific journal of cancer prevention : APJCP. 2015, 16(10):4223-4228. doi: 10.7314/apjcp.2015.16.10.4223.

31.        Zhao YQ, Chang IJ, Zhao FH, Hu SY, Smith JS, Zhang X, Li SM, Bai P, Zhang WH, Qiao YL. Distribution of cervical intraepithelial neoplasia on the cervix in Chinese women: pooled analysis of 19 population based screening studies. BMC cancer. 2015, 15:485. doi: 10.1186/s12885-015-1494-4.

32.        Zhou QH, Fan YG, Bu H, Wang Y, Wu N, Huang YC, Wang G, Wang XY, Qiao YL. China national lung cancer screening guideline with low-dose computed tomography (2015 version). Thoracic cancer. 2015, 6(6):812-818. doi: 10.1111/1759-7714.12287.

33.        Cai H, Ye F, Michel A, Murphy G, Sasazuki S, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH et al. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia. International journal of epidemiology. 2016, 45(3):774-781. doi: 10.1093/ije/dyw078.

34.        Chen W, Molijn A, Enqi W, Zhang X, Jenkins D, Yu X, Quint W, Schmidt JE, Li J, Pirog E et al. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China. International journal of cancer. 2016, 139(12):2687-2697. doi: 10.1002/ijc.30401.

35.        Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Qiao YL, Taylor PR, Smith JS, Galloway DA. Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case-control study. BMC cancer. 2016, 16:342. doi: 10.1186/s12885-016-2381-3.

36.        Fan Y, Jiang Y, Hu P, Chang R, Yao S, Wang B, Li X, Zhou Q, Qiao Y. Modification of association between prior lung disease and lung cancer by inhaled arsenic: A prospective occupational-based cohort study in Yunnan, China. Journal of exposure science & environmental epidemiology. 2016, 26(5):464-470. doi: 10.1038/jes.2016.22.

37.        Hu N, Kadota M, Liu H, Abnet CC, Su H, Wu H, Freedman ND, Yang HH, Wang C, Yan C et al. Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer. Cancer research. 2016, 76(7):1714-1723. doi: 10.1158/0008-5472.can-15-0338.

38.        Hu N, Wang Z, Song X, Wei L, Kim BS, Freedman ND, Baek J, Burdette L, Chang J, Chung C et al. Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut. 2016, 65(10):1611-1618. doi: 10.1136/gutjnl-2015-309340.

39.        Hyland PL, Zhang H, Yang Q, Yang HH, Hu N, Lin SW, Su H, Wang L, Wang C, Ding T et al. Pathway, in silico and tissue-specific expression quantitative analyses of oesophageal squamous cell carcinoma genome-wide association studies data. International journal of epidemiology. 2016, 45(1):206-220. doi: 10.1093/ije/dyv294.

40.        Katki HA, Zhao FH, Hu SY, Zhang Q, Qiao YL, Schiffman M. Reply to Letter: Using novel risk stratification statistics to better understand the value of screening tests. International journal of cancer. 2016, 139(7):1669. doi: 10.1002/ijc.30192.

41.        Liu YJ, Zhang Q, Hu SY, Zhao FH. Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China. BMC cancer. 2016, 16:164. doi: 10.1186/s12885-016-2207-3.

42.        Machiela MJ, Zhou W, Karlins E, Sampson JN, Freedman ND, Yang Q, Hicks B, Dagnall C, Hautman C, Jacobs KB et al. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nature communications. 2016, 7:11843. doi: 10.1038/ncomms11843.

43.        Molijn A, Jenkins D, Chen W, Zhang X, Pirog E, Enqi W, Liu B, Schmidt J, Cui J, Qiao Y et al. The complex relationship between human papillomavirus and cervical adenocarcinoma. International journal of cancer. 2016, 138(2):409-416. doi: 10.1002/ijc.29722.

44.        Pu D, Liang H, Wei F, Akin D, Feng Z, Yan Q, Li Y, Zhen Y, Xu L, Dong G et al. Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study. Thoracic cancer. 2016, 7(4):428-436. doi: 10.1111/1759-7714.12350.

45.        Qin Y, Zhang HY, Marlowe N, Fei MD, Yu J, Lei XQ, Yu LL, Zhang J, Cao D, Ma L et al. Evaluation of human papillomavirus detection by Abbott m2000 system on samples collected by FTA Elute (TM) Card in a Chinese HIV-1 positive population. Journal of Clinical Virology. 2016, 85:80-85. doi: 10.1016/j.jcv.2016.11.002.

46.        Ren J, Murphy G, Fan J, Dawsey SM, Taylor PR, Selhub J, Qiao Y, Abnet CC. Prospective study of serum B vitamins levels and oesophageal and gastric cancers in China. Scientific reports. 2016, 6:35281. doi: 10.1038/srep35281.

47.        Valdez M, Jeronimo J, Bansil P, Qiao YL, Zhao FH, Chen W, Zhang X, Kang LN, Paul P, Bai P et al. Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china. International journal of cancer. 2016, 138(6):1453-1461. doi: 10.1002/ijc.29877.

48.        Wang JB, Fan JH, Dawsey SM, Sinha R, Freedman ND, Taylor PR, Qiao YL, Abnet CC. Dietary components and risk of total, cancer and cardiovascular disease mortality in the Linxian Nutrition Intervention Trials cohort in China. Scientific reports. 2016, 6:22619. doi: 10.1038/srep22619.

49.        Wang SM, Fan JH, Jia MM, Yang Z, Zhang YQ, Qiao YL, Taylor PR. Body mass index and long-term risk of death from esophageal squamous cell carcinoma in a Chinese population. Thoracic cancer. 2016, 7(4):387-392. doi: 10.1111/1759-7714.12340.

50.        Yang Z, Holt HK, Fan JH, Ma L, Liu Y, Chen W, Como P, Zhang L, Qiao YL. Optimal Cutoff Scores for Alzheimer's Disease Using the Chinese Version of Mini-Mental State Examination Among Chinese Population Living in Rural Areas. American journal of Alzheimer's disease and other dementias. 2016, 31(8):650-657. doi: 10.1177/1533317516662336.

51.        Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ et al. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. Oncotarget. 2016, 7(16):21181-21189. doi: 10.18632/oncotarget.8307.

52.        Yu LL, Guo HQ, Lei XQ, Qin Y, Wu ZN, Kang LN, Zhang X, Qiao YL, Chen W. p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. Oncotarget. 2016, 7(40):64810-64819. doi: 10.18632/oncotarget.11705.

53.        Yu LL, Kang LN, Zhao FH, Lei XQ, Qin Y, Wu ZN, Wang H, Chen W, Qiao YL. Elevated Expression of Human Papillomavirus-16/18 E6 Oncoprotein Associates with Persistence of Viral Infection: A 3-Year Prospective Study in China. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016, 25(7):1167-1174. doi: 10.1158/1055-9965.epi-15-1057.

54.        Yuan W, Tang W, Xie Y, Wang S, Chen Y, Qi J, Qiao Y, Ma J. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer. Oncotarget. 2016, 7(48):80033-80045. doi: 10.18632/oncotarget.12406.

55.        Zhang Q, Liu YJ, Hu SY, Zhao FH. Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China. BMC cancer. 2016, 16(1):848. doi: 10.1186/s12885-016-2893-x.

56.        Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL et al. Risk assessment to guide cervical screening strategies in a large Chinese population. International journal of cancer. 2016, 138(11):2639-2647. doi: 10.1002/ijc.30012.

57.        Zheng R, Zeng H, Zuo T, Zhang S, Qiao Y, Zhou Q, Chen W. Lung cancer incidence and mortality in China, 2011. Thoracic cancer. 2016, 7(1):94-99. doi: 10.1111/1759-7714.12286.

58.        Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, Gupta PC, Sawada N, Tamakoshi A, Shu XO et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia. 2017, 60(6):1022-1032. doi: 10.1007/s00125-017-4229-z.

59.        Dong L, Feng RM, Zhang L, Xu XQ, Zhao XL, Wang MZ, Qiao YL, Zhao FH. Prospective comparison of hybrid capture 2 and SPF??-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China. Journal of gynecologic oncology. 2017, 28(5):e66. doi: 10.3802/jgo.2017.28.e66.

60.        Dong L, Hu SY, Zhang Q, Feng RM, Zhang L, Zhao XL, Zhang X, Qiao YL, Zhao FH. Risk Prediction of Cervical Cancer and Precancers by Type-Specific Human Papillomavirus: Evidence from a Population-Based Cohort Study in China. Cancer prevention research (Philadelphia, Pa). 2017, 10(12):745-751. doi: 10.1158/1940-6207.capr-17-0088.

61.        Dong L, Lin C, Li L, Wang M, Cui J, Feng R, Liu B, Wu Z, Lian J, Liao G et al. An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2017, 94:67-71. doi: 10.1016/j.jcv.2017.06.008.

62.        Fan JH, Wang JB, Wang SM, Abnet CC, Qiao YL, Taylor PR. Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort. Cancer science. 2017, 108(8):1667-1672. doi: 10.1111/cas.13292.

63.        Fan JH, Zhang YQ, Shi SS, Chen YJ, Yuan XH, Jiang LM, Wang SM, Ma L, He YT, Feng CY et al. A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china. Oncotarget. 2017, 8(42):71699-71708. doi: 10.18632/oncotarget.17599.

64.        Feng RM, Hu SY, Zhao FH, Zhang R, Zhang X, Wallach AI, Qiao YL. Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse. Journal of gynecologic oncology. 2017, 28(5):e47. doi: 10.3802/jgo.2017.28.e47.

65.        Ginsburg O, Badwe R, Boyle P, Derricks G, Dare A, Evans T, Eniu A, Jimenez J, Kutluk T, Lopes G et al. Changing global policy to deliver safe, equitable, and affordable care for women's cancers. Lancet (London, England). 2017, 389(10071):871-880. doi: 10.1016/s0140-6736(16)31393-9.

66.        Holt HK, Zhang L, Zhao FH, Hu SY, Zhao XL, Zhang X, Pan QJ, Zhang WH, Smith JS, Qiao YL. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China. International journal of cancer. 2017, 140(3):544-554. doi: 10.1002/ijc.30468.

67.        Hu SY, Zhang WH, Li SM, Li N, Huang MN, Pan QJ, Zhang X, Han Y, Zhao FH, Chen W et al. Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy. Medicine. 2017, 96(17):e6689. doi: 10.1097/md.0000000000006689.

68.        Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, Luciani S, Murokora D, Ngoma T, Qiao Y et al. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. Journal of global oncology. 2017, 3(5):635-657. doi: 10.1200/jgo.2016.006577.

69.        Li Q, Yang Z, Fan J, He J, Zhang B, Yang H, Xie X, Tang Z, Li H, Qiao Y et al. A nation-wide multicenter 10-year (1999-2008) retrospective study of chemotherapy in Chinese breast cancer patients. Oncotarget. 2017, 8(44):75864-75873. doi: 10.18632/oncotarget.16439.

70.        Li Y, Shi J, Yu S, Wang L, Liu J, Ren J, Gao S, Hui Z, Li J, Wu N et al. Effect of socioeconomic status on stage at diagnosis of lung cancer in a hospital-based multicenter retrospective clinical epidemiological study in China, 2005-2014. Cancer medicine. 2017, 6(10):2440-2452. doi: 10.1002/cam4.1170.

71.        Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer biology & medicine. 2017, 14(1):33-41. doi: 10.20892/j.issn.2095-3941.2016.0093.

72.        Liang H, Yang Z, Wang JB, Yu P, Fan JH, Qiao YL, Taylor PR. Association between oral leukoplakia and risk of upper gastrointestinal cancer death: A follow-up study of the Linxian General Population Trial. Thoracic cancer. 2017, 8(6):642-648. doi: 10.1111/1759-7714.12501.

73.        Lin CQ, Zeng X, Cui JF, Liao GD, Wu ZN, Gao QQ, Zhang X, Yu XZ, Chen W, Xi MR et al. Correction for Lin et al., "Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test". Journal of clinical microbiology. 2017, 55(6):1972. doi: 10.1128/jcm.00598-17.

74.        Lin CQ, Zeng X, Cui JF, Liao GD, Wu ZN, Gao QQ, Zhang X, Yu XZ, Chen W, Xi MR et al. Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test. Journal of clinical microbiology. 2017, 55(2):568-573. doi: 10.1128/jcm.02025-16.

75.        Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, Kikuchi S, Inoue M, Tanaka H, He Y. Esophageal cancer in high-risk areas of China: research progress and challenges. Annals of epidemiology. 2017, 27(3):215-221. doi: 10.1016/j.annepidem.2016.11.004.

76.        Liu Y, Zhang J, Huang R, Feng WL, Kong YN, Xu F, Zhao L, Song QK, Li J, Zhang BN et al. Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study. Medicine. 2017, 96(15):e6641. doi: 10.1097/md.0000000000006641.

77.        Song X, Li WQ, Hu N, Zhao XK, Wang Z, Hyland PL, Jiang T, Kong GQ, Su H, Wang C et al. GWAS follow-up study of esophageal squamous cell carcinoma identifies potential genetic loci associated with family history of upper gastrointestinal cancer. Scientific reports. 2017, 7(1):4642. doi: 10.1038/s41598-017-04822-2.

78.        Song Y, Zhao YQ, Li L, Pan QJ, Li N, Zhao FH, Chen W, Zhang X, Qiao YL. A retrospective analysis of the utility of endocervical curettage in screening population. Oncotarget. 2017, 8(30):50141-50147. doi: 10.18632/oncotarget.15658.

79.        Wang HR, Li YC, Guo HQ, Yu LL, Wu ZN, Yin J, Liao GD, Qu YM, Jiang Y, Wang D et al. A cocktail of p16(INK4a) and Ki-67, p16(INK4a) and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening. Oncotarget. 2017, 8(48):83890-83899. doi: 10.18632/oncotarget.19870.

80.        Wang M, Hu S, Zhao S, Zhang W, Pan Q, Zhang X, Chen F, Han J, Ma J, Smith JS et al. Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in China. Chin J Cancer Res. 2017, 29(6):496-509. doi: 10.21147/j.issn.1000-9604.2017.06.04.

81.        Wang Z, Dai J, Hu N, Miao X, Abnet CC, Yang M, Freedman ND, Chen J, Burdette L, Zhu X et al. Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. Gut. 2017, 66(4):581-587. doi: 10.1136/gutjnl-2015-310612.

82.        Wu ZN, Qin Y, Yu LL, Lin CQ, Wang H, Cui JF, Liu B, Liao YQ, Warren D, Zhang X et al. Association Between Human Papillomavirus (HPV) 16, HPV18, and Other HR-HPV Viral Load and the Histological Classification of Cervical Lesions: Results From a Large-Scale Cross-Sectional Study. Journal of Medical Virology. 2017, 89(3):535-541. doi: 10.1002/jmv.24645.

83.        Zhang J, Li X, Huang R, Feng WL, Kong YN, Xu F, Zhao L, Song QK, Li J, Zhang BN et al. A nomogram to predict the probability of axillary lymph node metastasis in female patients with breast cancer in China: A nationwide, multicenter, 10-year epidemiological study. Oncotarget. 2017, 8(21):35311-35325. doi: 10.18632/oncotarget.13330.

84.        Zhang Q, Dong L, Hu S, Feng R, Zhang X, Pan Q, Ma J, Zhang L, Zhao X, Sankaranarayanan Ret al. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China. International journal of cancer. 2017, 141(6):1110-1119. doi: 10.1002/ijc.30807.

85.        Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. Journal of gynecologic oncology. 2017, 28(4):e30. doi: 10.3802/jgo.2017.28.e30.

86.        Zhu FC, Hu SY, Hong Y, Hu YM, Zhang X, Zhang YJ, Pan QJ, Zhang WH, Zhao FH, Zhang CF et al. Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25?years: event-triggered analysis of a randomized controlled trial. Cancer medicine. 2017, 6(1):12-25. doi: 10.1002/cam4.869.

87.        Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N et al. Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study. Annals of internal medicine. 2018, 168(1):20-29. doi: 10.7326/m17-1609.

88.        Chen W, Sun HK, Molijn A, Zeng L, Kang LN, Jenkins D, Zhang SK, Cui JF, Wu ZN, Pirog E et al. The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China. Journal of Lower Genital Tract Disease. 2018, 22(4):355-361. doi: 10.1097/lgt.0000000000000408.

89.        Dong L, Wang MZ, Zhao XL, Feng RM, Hu SY, Zhang Q, Smith JS, Qiao YL, Zhao FH. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study. Gynecologic oncology. 2018, 148(1):103-110. doi: 10.1016/j.ygyno.2017.11.016.

90.        Dong L, Yin J, Zhao J, Ma SR, Wang HR, Wang M, Chen W, Wei WQ. Microbial Similarity and Preference for Specific Sites in Healthy Oral Cavity and Esophagus. Frontiers in Microbiology. 2018, 9. doi: 10.3389/fmicb.2018.01603.

91.        Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL et al. Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2018, 27(12):1472-1479. doi: 10.1158/1055-9965.epi-18-0582.

92.        Fan JH, Wang JB, Wang SM, Abnet CC, Qiao YL, Taylor PR. Longitudinal change in blood pressure is associated with cardiovascular disease mortality in a Chinese cohort. Heart (British Cardiac Society). 2018, 104(21):1764-1771. doi: 10.1136/heartjnl-2017-312850.

93.        Feng RM, M ZW, Smith JS, Dong L, Chen F, Pan QJ, Zhang X, Qiao YL, Zhao FH. Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2018, 99-100:84-90. doi: 10.1016/j.jcv.2017.12.015.

94.        Hsieh E, Wang Q, Zhang R, Niu X, Xia W, Fraenkel L, Insogna KL, Li J, Smith JS, Zhou C et al. Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps. BMC cancer. 2018, 18(1):104. doi: 10.1186/s12885-018-4014-5.

95.        Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo Cancela M, Gupta P, Meheus F, Qiao YL, Sitas F et al. Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison. Cancer epidemiology. 2018, 53:27-34. doi: 10.1016/j.canep.2017.12.013.

96.        Rezhake R, Hu SY, Zhao YQ, Zhang L, Zhao XL, Dominguez AZ, Qiao YL, Zhou CH, Zhao FH. Impact of International Collaborative Training Programs on Medical Students' Research Ability. Journal of cancer education : the official journal of the American Association for Cancer Education. 2018, 33(3):511-516. doi: 10.1007/s13187-016-1134-y.

97.      Thistle JE, Yang B, Petrick JL, Fan JH, Qiao YL, Abnet CC, Taylor PR, McGlynn KA. Association of tooth loss with liver cancer incidence and chronic liver disease mortality in a rural Chinese population. PloS one. 2018, 13(9):e0203926. doi: 10.1371/journal.pone.0203926.

98.      Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH et al. Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia. Digestive diseases and sciences. 2018, 63(10):2765-2772. doi: 10.1007/s10620-018-5154-9.

99.      Wang SM, Fan JH, Taylor PR, Lam TK, Dawsey SM, Qiao YL, Abnet CC. Association of plasma vitamin C concentration to total and cause-specific mortality: a 16-year prospective study in China. Journal of epidemiology and community health. 2018, 72(12):1076-1082. doi: 10.1136/jech-2018-210809.

100.      Wang SM, Taylor PR, Fan JH, Pfeiffer RM, Gail MH, Liang H, Murphy GA, Dawsey SM, Qiao YL, Abnet CC. Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial. Journal of the National Cancer Institute. 2018, 110(11):1229-1238. doi: 10.1093/jnci/djy043.

101.      Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, Wang HHX, Chiu PWY, Ng EKW, Wu JCY et al. Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Scientific reports. 2018, 8(1):4522. doi: 10.1038/s41598-018-19819-8.

102.      Wu Z, Yu L, Lei X, Qin Y, Zhang X, Chen W, Qiao Y. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2018, 108:6-11. doi: 10.1016/j.jcv.2018.08.008.

103.      Wu ZN, Yu LL, Lei XQ, Qin Y, Zhang X, Chen W, Qiao YL. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer. Journal of Clinical Virology. 2018, 108:6-11. doi: 10.1016/j.jcv.2018.08.008.

104.      Xue L, Hu W, Zhang H, Xie Z, Zhang X, Zhao F, Qiao Y, Gao L, Ma W. Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China. Human vaccines & immunotherapeutics. 2018, 14(2):404-411. doi: 10.1080/21645515.2017.1393132.

105.      Yu L, Jiang M, Qu P, Wu Z, Sun P, Xi M, Qin Y, Liu X, Liao G, Lei X et al. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage. International journal of cancer. 2018, 143(4):813-822. doi: 10.1002/ijc.31368.

106.      Yu LL, Jiang MY, Qu PP, Wu ZN, Sun PS, Xi MR, Qin Y, Liu X, Liao GD, Lei XQ et al. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage. International Journal of Cancer. 2018, 143(4):813-822. doi: 10.1002/ijc.31368.

107.      Zhang L, Xu XQ, Hu SY, Chen F, Zhang X, Pan QJ, Zhang WH, Feng RM, Dong L, Zhang Q et al. Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China. Gynecologic oncology. 2018, 151(2):221-228. doi: 10.1016/j.ygyno.2018.09.012.

108.      Zhang X, Lin X, Tan Y, Zhu Y, Wang H, Feng R, Tang G, Zhou X, Li A, Qiao Y. A multicenter hospital-based diagnosis study of automated breast ultrasound system in detecting breast cancer among Chinese women. Chin J Cancer Res. 2018, 30(2):231-239. doi: 10.21147/j.issn.1000-9604.2018.02.06.

109.      Butt J, Varga MG, Wang T, Tsugane S, Shimazu T, Zheng W, Abnet CC, Yoo KY, Park SK, Kim Jet al. Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea. Cancer prevention research (Philadelphia, Pa). 2019, 12(10):667-674. doi: 10.1158/1940-6207.capr-19-0238.

110.      Chen W, Zhao Y, Xie X, Liu JH, Li JR, Zhao C, Wang SM, Liao XY, Shou Q, Zheng MH et al. Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up. Vaccine. 2019, 37(6):889-897. doi: 10.1016/j.vaccine.2018.12.030.

111.      Dong L, Li T, Li L, Wang MZ, Wu Z, Cui J, Liu B, Zhang X, Qiao Y, Chen W. Clustering patterns of type-type combination in multiple genotypes infections of human papillomavirus in cervical adenocarcinoma. Journal of medical virology. 2019, 91(11):2001-2008. doi: 10.1002/jmv.25553.

112.      Guo L, Zhang S, Liu S, Zheng L, Chen Q, Cao X, Sun X, Qiao Y, Zhang J. Determinants of participation and detection rate of upper gastrointestinal cancer from population-based screening program in China. Cancer medicine. 2019, 8(16):7098-7107. doi: 10.1002/cam4.2578.

113.      Hou DH, Zhao SJ, Shi JF, Wang L, Wang DB, Huang YC, Liao XZ, Xing XJ, Du LB, Yang L et al. Lung cancer imaging methods in China from 2005 to 2014: A national, multicenter study. Thoracic cancer. 2019, 10(4):708-714. doi: 10.1111/1759-7714.12988.

114.      Li Y, Ma L, Yang C, Chen Z, Zhao Y, Dang L, Lang J, Qiao Y. A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China. Chin J Cancer Res. 2019, 31(5):838-848. doi: 10.21147/j.issn.1000-9604.2019.05.13.

115.      Liu AQ, Vogtmann E, Shao DT, Abnet CC, Dou HY, Qin Y, Su Z, Wei WQ, Chen W. A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 2019, 28(12):2030-2037. doi: 10.1158/1055-9965.Epi-18-1210.

116.      Liu YJ, Keane A, Simms KT, Lew JB, Shi JF, Mazariego C, Yuill S, Jeronimo J, Qiao YL, Canfell K. Development and application of a framework to estimate health care costs in China: The cervical cancer example. PloS one. 2019, 14(10):e0222760. doi: 10.1371/journal.pone.0222760.

117.      Ma L, Wang Y, Gao X, Dai Y, Zhang Y, Wang Z, Wang X, Wang L, Jiang J, Jing X et al. Economic evaluation of cervical cancer screening strategies in urban China. Chin J Cancer Res. 2019, 31(6):974-983. doi: 10.21147/j.issn.1000-9604.2019.06.13.

118.      Men Y, Wang L, Zhang Y, Gao S, Li J, Wu N, Yang B, Liu S, Ren J, Huang Y et al. Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10-Year (2005-2014) Retrospective Clinical Epidemiological Study. Frontiers in oncology. 2019, 9:786. doi: 10.3389/fonc.2019.00786.

119.      Pirog EC, Park KJ, Kiyokawa T, Zhang X, Chen W, Jenkins D, Quint W. Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances. Advances in Anatomic Pathology. 2019, 26(1):1-12. doi: 10.1097/pap.0000000000000216.

120.      Pretorius RG, Belinson JL, Burchette RJ, Wu R, Qiao YL. Key Determinants of the Value of Random Cervical Biopsy at Colposcopy. Journal of lower genital tract disease. 2019, 23(4):241-247. doi: 10.1097/lgt.0000000000000485.

121.      Rezhake R, Hu SY, Zhao S, Xu XQ, Zhao XL, Zhang L, Wang Y, Zhang X, Pan QJ, Qiao YL et al. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women. International journal of cancer. 2019, 144(1):34-42. doi: 10.1002/ijc.31633.

122.      Rezhake R, Xu XQ, Montigny S, Berger A, Hu SY, Liu ZH, Sankaranarayanan R, Qiao YL, Basu P, Zhao FH. Training Future Leaders: Experience from China-ASEAN Cancer Control Training Program. Journal of cancer education : the official journal of the American Association for Cancer Education. 2019, 34(6):1067-1073. doi: 10.1007/s13187-018-1409-6.

123.      Shi JF, Wang L, Wu N, Li JL, Hui ZG, Liu SM, Yang BY, Gao SG, Ren JS, Huang HY et al. Clinical characteristics and medical service utilization of lung cancer in China, 2005-2014: Overall design and results from a multicenter retrospective epidemiologic survey. Lung cancer (Amsterdam, Netherlands). 2019, 128:91-100. doi: 10.1016/j.lungcan.2018.11.031.

124.      Si M, Su X, Jiang Y, Qiao Y, Liu Y. Interventions to improve human papillomavirus vaccination among Chinese female college students: study protocol for a randomized controlled trial. BMC public health. 2019, 19(1):1546. doi: 10.1186/s12889-019-7903-x.

125.      Su B, Luo P, Yang Z, Yu P, Li Z, Yin P, Zhou L, Fan J, Huang X, Lin X et al. A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data. Analytical and bioanalytical chemistry. 2019, 411(24):6377-6386. doi: 10.1007/s00216-019-02011-w.

126.      Totsuka Y, Lin Y, He Y, Ishino K, Sato H, Kato M, Nagai M, Elzawahry A, Totoki Y, Nakamura Het al. DNA Adductome Analysis Identifies N-Nitrosopiperidine Involved in the Etiology of Esophageal Cancer in Cixian, China. Chemical research in toxicology. 2019, 32(8):1515-1527. doi: 10.1021/acs.chemrestox.9b00017.

127.      Wang MZ, Feng RM, Wang S, Duan XZ, Li D, Zhang X, Mu R, Qiao Y, Smith JS. Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China. Sexually transmitted diseases. 2019, 46(8):540-547. doi: 10.1097/olq.0000000000001026.

128.      Wang SM, Abnet CC, Qiao YL. What have we learned from Linxian esophageal cancer etiological studies? Thoracic cancer. 2019, 10(5):1036-1042. doi: 10.1111/1759-7714.13058.

129.      Wang SM, Roth MJ, Murphy GA, Dawsey SM, Fan JH, Taylor PR, Qiao YL, Abnet CC. Serologic Profile of Antiparietal Cell Antibodies, Pepsinogens, and H. pylori and Risk of Upper Gastrointestinal Cancer: A Nested Case-Control Study in China. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2019, 28(12):2022-2029. doi: 10.1158/1055-9965.Epi-19-0512.

130.      Wei L, Xie X, Liu J, Zhao Y, Chen W, Zhao C, Wang S, Liao X, Shou Q, Qiu Y et al. Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up. Vaccine. 2019, 37(27):3617-3624. doi: 10.1016/j.vaccine.2018.08.009.

131.      Wu Z, Li TY, Jiang M, Yu L, Zhao J, Wang H, Zhang X, Chen W, Qiao Y. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes. Cancer prevention research (Philadelphia, Pa). 2019, 12(2):95-102. doi: 10.1158/1940-6207.capr-18-0343.

132.      Wu ZN, Li TY, Jiang MY, Yu LL, Zhao J, Wang HR, Zhang X, Chen W, Qiao YL. Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes. Cancer Prevention Research. 2019, 12(2):95-101. doi: 10.1158/1940-6207.Capr-18-0343.

133.      Xia C, Hu S, Xu X, Zhao X, Qiao Y, Broutet N, Canfell K, Hutubessy R, Zhao F. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. The Lancet Public health. 2019, 4(9):e462-e472. doi: 10.1016/s2468-2667(19)30162-8.

134.      Xing PY, Zhu YX, Wang L, Hui ZG, Liu SM, Ren JS, Zhang Y, Song Y, Liu CC, Huang YC et al. What are the clinical symptoms and physical signs for non-small cell lung cancer before diagnosis is made? A nation-wide multicenter 10-year retrospective study in China. Cancer medicine. 2019, 8(8):4055-4069. doi: 10.1002/cam4.2256.

135.      Xue P, Gao LL, Yin J, Han LL, Zhao J, Li L, Seery S, Han XY, Li TY, Jiang Y et al. A direct comparison of four high-risk human papillomavirus tests versus the cobas test: Detecting CIN2 in low-resource settings. Journal of Medical Virology. 2019, 91(7):1342-1350. doi: 10.1002/jmv.25451.

136.      Yang JJ, Yu D, Wen W, Saito E, Rahman S, Shu XO, Chen Y, Gupta PC, Gu D, Tsugane S et al. Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants. JAMA network open. 2019, 2(4):e192696. doi: 10.1001/jamanetworkopen.2019.2696.

137.      Yang JJ, Yu D, Wen W, Shu XO, Saito E, Rahman S, Gupta PC, He J, Tsugane S, Xiang YB et al. Tobacco Smoking and Mortality in Asia: A Pooled Meta-analysis. JAMA network open. 2019, 2(3):e191474. doi: 10.1001/jamanetworkopen.2019.1474.

138.      Zhang H, Xie P, Li Z, Huang R, Feng W, Kong Y, Xu F, Zhao L, Song Q, Li J et al. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study. Diagnostic pathology. 2019, 14(1):35. doi: 10.1186/s13000-019-0806-4.

139.      Zhang S, Yu P, Wang JB, Fan JH, Qiao YL, Taylor PR. Association between tooth loss and upper gastrointestinal cancer: A 30-year follow-up of the Linxian Dysplasia Nutrition Intervention Trial Cohort. Thoracic cancer. 2019, 10(4):966-974. doi: 10.1111/1759-7714.13037.

140.      Zhang SK, Jia MM, Zhao DM, Wu ZN, Guo Z, Liu YL, Guo PP, Chen Q, Cao XQ, Liu SZ et al. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China. Cancer Epidemiology. 2019, 59:123-128. doi: 10.1016/j.canep.2018.12.013.

141.      Zhao F, Qiao Y. Cervical cancer prevention in China: a key to cancer control. Lancet (London, England). 2019, 393(10175):969-970. doi: 10.1016/s0140-6736(18)32849-6.

142.      Aballéa S, Beck E, Cheng X, Demarteau N, Li X, Ma F, Neine M, Zhao FH. Risk factors for cervical cancer in women in China: A meta-model. Women's health (London, England). 2020, 16:1745506520940875. doi: 10.1177/1745506520940875.

143.      Chen H, Zhang X, Wang W, Zhang R, Du M, Shan L, Li Y, Wang X, Liu Y, Zhang W et al. Effect of an educational intervention on human papillomavirus (HPV) knowledge and attitudes towards HPV vaccines among healthcare workers (HCWs) in Western China. Human vaccines & immunotherapeutics. 2020:1-8. doi: 10.1080/21645515.2020.1780093.

144.      Chua GT, Ho FK, Tung KT, Wong RS, Cheong KN, Yip PS, Fan SY, Wong WH, Qiao Y, Chui CS et al. Sexual behaviors and intention for cervical screening among HPV-vaccinated young Chinese females. Vaccine. 2020, 38(5):1025-1031. doi: 10.1016/j.vaccine.2019.11.044.

145.      Dong L, Zhang L, Hu SY, Feng RM, Zhao XL, Zhang Q, Pan QJ, Zhang X, Qiao YL, Zhao FH. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study. Clinical epigenetics. 2020, 12(1):62. doi: 10.1186/s13148-020-00853-1.

146.      Duan R, Qiao Y, Clifford G, Zhao F. Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China. Cancer medicine. 2020, 9(1):374-384. doi: 10.1002/cam4.2697.

147.      Feng H, Song G, Ma S, Ma Q, Li X, Wei W, Abnet C, Qiao Y, Wang G. The optimal starting age of endoscopic screening for esophageal squamous cell cancer in high prevalence areas in China. Journal of gastroenterology and hepatology. 2020, 35(10):1761-1768. doi: 10.1111/jgh.15090.

148.      Hu SY, Rezhake R, Chen F, Zhang X, Pan QJ, Ma JF, Qiao YL, Zhao FH. Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China. Gynecologic oncology. 2020, 156(3):616-623. doi: 10.1016/j.ygyno.2019.12.027.

149.      Hu SY, Tsang SH, Chen F, Pan QJ, Zhang WH, Hong Y, Sampson JN, Hildesheim A, Zhao FH, Kreimer AR. Association between Common Vaginal Infections and Cervical Non-HPV16/18 Infection in HPV-Vaccinated Women. The Journal of infectious diseases. 2020. doi: 10.1093/infdis/jiaa384.

150.      Jang J, Wang T, Cai H, Ye F, Murphy G, Shimazu T, Taylor PR, Qiao YL, Yoo KY, Jee SH et al. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies. International journal of cancer. 2020, 147(3):777-784. doi: 10.1002/ijc.32790.

151.      Jia M, Lin X, Zhou X, Yan H, Chen Y, Liu P, Bao L, Li A, Basu P, Qiao Y et al. Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts. Breast cancer research and treatment. 2020, 181(3):589-597. doi: 10.1007/s10549-020-05625-2.

152.      Jiang MY, Wu ZN, Li TY, Yu LL, Zhang SK, Zhang X, Qu PP, Sun PS, Xi MR, Liu X et al. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women. Cancer Prevention Research. 2020, 13(2):163-171. doi: 10.1158/1940-6207.Capr-19-0144.

153.      Li TY, Wu ZN, Jiang MY, Zhao YQ, Yu LL, Qin Y, Liu B, Cui JF, Li L, Pan QJ et al. Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women. Gynecologic Oncology. 2020, 157(1):202-208. doi: 10.1016/j.ygyno.2020.01.011.

154.      Li Y, Chen J, Xue P, Tang C, Chang J, Chu C, Ma K, Li Q, Zheng Y, Qiao Y. Computer-aided Cervical Cancer Diagnosis using Time-lapsed Colposcopic Images. IEEE transactions on medical imaging. 2020, Pp. doi: 10.1109/tmi.2020.2994778.

155.      Liao GD, Jiang XY, She B, Tang HJ, Wang ZY, Zhou HR, Ma Y, Xu WD, Xu HX, Chen W et al. Multi-Infection Patterns and Co-infection Preference of 27 Human Papillomavirus Types Among 137,943 Gynecological Outpatients Across China. Frontiers in Oncology. 2020, 10. doi: 10.3389/fonc.2020.00449.

156.      Lin X, Jia M, Zhou X, Bao L, Chen Y, Liu P, Feng R, Zhang X, Zhu L, Wang H et al. The diagnostic performance of automated versus handheld breast ultrasound and mammography in symptomatic outpatient women: a multicenter, cross-sectional study in China. European radiology. 2020. doi: 10.1007/s00330-020-07197-7.

157.      Naizhaer G, Yuan J, Mijiti P, Aierken K, Abulizi G, Qiao Y. Evaluation of multiple screening methods for cervical cancers in rural areas of Xinjiang, China. Medicine. 2020, 99(6):e19135. doi: 10.1097/md.0000000000019135.

158.      Pritchett NR, Maziarz M, Shu XO, Kamangar F, Dawsey SM, Fan JH, Ji BT, Gao YT, Xiang YB, Qiao YL et al. Serum ghrelin and esophageal and gastric cancer in two cohorts in China. International journal of cancer. 2020, 146(10):2728-2735. doi: 10.1002/ijc.32597.

159.      Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ et al. Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial. Journal of the National Cancer Institute. 2020, 112(2):145-153. doi: 10.1093/jnci/djz074.

160.      Rezhake R, Chen F, Hu SY, Zhao XL, Zhang X, Cao J, Qiao YL, Zhao FH, Arbyn M. Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China. International journal of cancer. 2020, 147(8):2053-2064. doi: 10.1002/ijc.33001.

161.      Si MY, Su XY, Jiang Y, Wang WJ, Gu XF, Ma L, Li J, Zhang SK, Ren ZF, Ren R et al. Psychological impact of COVID-19 on medical care workers in China. Infectious diseases of poverty. 2020, 9(1):113. doi: 10.1186/s40249-020-00724-0.

162.      Su YY, Lin BZ, Zhao H, Li J, Lin ZJ, Qiao YL, Wei LH, Hu YM, Li RC, Zhuang SJ et al. Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial. Human vaccines & immunotherapeutics. 2020, 16(7):1636-1644. doi: 10.1080/21645515.2019.1691413.

163.      Wang YH, Li JQ, Shi JF, Que JY, Liu JJ, Lappin JM, Leung J, Ravindran AV, Chen WQ, Qiao YL et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Molecular psychiatry. 2020, 25(7):1487-1499. doi: 10.1038/s41380-019-0595-x.

164.      Wei MN, Su Z, Wang JN, Gonzalez Mendez MJ, Yu XY, Liang H, Zhou QH, Fan YG, Qiao YL. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study. Thoracic cancer. 2020, 11(5):1224-1232. doi: 10.1111/1759-7714.13379.

165.      Wei WQ, Hao CQ, Guan CT, Song GH, Wang M, Zhao DL, Li BY, Bai WL, Hou PY, Wang JW et al. Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China. The American journal of gastroenterology. 2020, 115(7):1036-1044. doi: 10.14309/ajg.0000000000000640.

166.      Xing PY, Wang SZ, Shi JF, Wang L, Hui ZG, Ren JS, Liu SM, Qiao YL, Dai M, Li JL. Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005-2014) Retrospective Study. Cancer management and research. 2020, 12:6033-6044. doi: 10.2147/cmar.s253789.

167.      Xu H, Gonzalez MJ, Guo L, Chen Q, Zheng L, Chen P, Cao X, Liu S, Sun X, Zhang S et al. Knowledge, Awareness, and Attitudes Towards COVID-19 Pandemic Among Different Populations in Central China: A Cross-Sectional Survey. Journal of medical Internet research. 2020. doi: 10.2196/22628.

168.      Xu H, Yu Y, George W, Smith JS, Hu S, Dang L, Zhang X, Pan Q, Qiao Y, Zhao F. Comparison of the performance of paired urine and cervical samples for cervical cancer screening in screening population. Journal of medical virology. 2020, 92(2):234-240. doi: 10.1002/jmv.25597.

169.      Xue P, Ng MTA, Qiao Y. The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence. BMC medicine. 2020, 18(1):169. doi: 10.1186/s12916-020-01613-x.

170.      Yang H, Zhang S, Wang J, Fan J, Qiao Y, Taylor PR. Oral leukoplakia and the long-term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population. Thoracic cancer. 2020, 11(10):2804-2811. doi: 10.1111/1759-7714.13595.

171.      Yang H, Zhang S, Yan H, Wang J, Fan J, Qiao Y, Taylor PR. Fresh fruit consumption may decrease the long-term risk of esophageal cancer mortality: A 30-year follow-up study in the Linxian Dysplasia Nutrition Intervention trial (NIT). Thoracic cancer. 2020, 11(7):1918-1926. doi: 10.1111/1759-7714.13482.

172.      Yi ZB, Yu P, Zhang S, Wang WN, Han YQ, Ouyang QC, Yan M, Wang XJ, Hu XC, Jiang ZF et al. Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study. International journal of cancer. 2020. doi: 10.1002/ijc.33227.

173.      Yin J, Yin LY, Freedman ND, Li TY, Dawsey SM, Cui JF, Taylor PR, Liu B, Fan JH, Chen W et al. Independent and Joint Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer: A Prospective Nested Case-Control Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2020, 29(10):2057-2064. doi: 10.1158/1055-9965.Epi-20-0417.

174.      Yu XJ, Li J, Lin ZJ, Zhao H, Lin BZ, Qiao YL, Hu YM, Wei LH, Li RC, Huang WD et al. Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals. Human vaccines & immunotherapeutics. 2020, 16(7):1630-1635. doi: 10.1080/21645515.2020.1761202.

175.      Zhang DY, Chen W, Zhang HY, Lv SQ, Lu XN, Tao YP, Zhang M, Liu JF, Yang M, Qiao YL et al. Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China. The Kaohsiung journal of medical sciences. 2020, 36(6):450-459. doi: 10.1002/kjm2.12175.

176.      Zhang J, Xu H, Zheng L, Yu J, Chen Q, Cao X, Liu S, Jose Gonzalez M, Guo L, Sun X et al. Determinants of Participation and Detection Rate of Colorectal Cancer From a Population-Based Screening Program in China. Frontiers in oncology. 2020, 10:1173. doi: 10.3389/fonc.2020.01173.

177.      Zhang S, Wang JB, Yang H, Fan JH, Qiao YL, Taylor PR. Body mass index and risk of upper gastrointestinal cancer: A 30-year follow-up of the Linxian dysplasia nutrition intervention trial cohort. Cancer epidemiology. 2020, 65:101683. doi: 10.1016/j.canep.2020.101683.

178.      Zhang X, Liu CR, Wang ZZ, Ren ZF, Feng XX, Ma W, Gao XH, Zhang R, Brown MD, Qiao YL et al. Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study. Vaccine. 2020, 38(20):3665-3670. doi: 10.1016/j.vaccine.2020.03.032.

179.      Zhao F, Wen Y, Li Y, Tao S, Ma L, Zhao Y, Dang L, Wang Y, Zhao F, Lang J et al. Epidemiologic and Health Economic Evaluation of Cervical Cancer Screening in Rural China. Asian Pacific journal of cancer prevention : APJCP. 2020, 21(5):1317-1325. doi: 10.31557/apjcp.2020.21.5.1317.

180.      Zhao XL, Liu ZH, Zhao S, Hu SY, Muwonge R, Duan XZ, Du LJ, Su CF, Xiang XE, Zhang X et al. Efficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in China. International journal of cancer. 2020. doi: 10.1002/ijc.33290.

181.      Zhao XL, Xu XQ, Duan XZ, Rezhake R, Hu SY, Wang Y, Xia CF, Zhang X, Qiao YL, Sankaranarayanan R et al. Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: A population-based study in rural China. International journal of cancer. 2020, 147(5):1275-1285. doi: 10.1002/ijc.32881.

182.      Zhao Y, Zhao F, Hu S, Zhang X, Zhang W, Pan Q, Gage JC, Sankaranarayanan R, Qiao Y. Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies. Chin J Cancer Res. 2020, 32(3):383-394. doi: 10.21147/j.issn.1000-9604.2020.03.09.

183.  Su Zhang, Xin Lu, Chunxiu Hu, Yanli Li, Huan Yang, Huijiao Yan, Jinhu Fan,* Guowang Xu,*

Christian C. Abnet, and Youlin Qiao. Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry.ACS Omega.2020.

https://dx.doi.org/10.1021/acsomega.0c02600

二、中文文章：

[1] 曾晓敏, 任泽舫, 魏雪灵, 林威, 乔友林. 中山大学本科生对HPV及疫苗认知的调查 [J]. 现代预防医学, 2015, 42(10): 1822-5.

[2] 段仙芝, 宋艳波, 王少明, 朱趁芬, 娜仁托娅, 张永东, 乔友林. 宫颈液基细胞学结果与高危型人乳头瘤病毒的相关性[J]. 中国肿瘤, 2015, 24(01): 76-80.

[3] 飞秋月, 张红芸, 徐琳, 赵耀, 冯琳, 将成芹, 乔友林. HIV感染妇女宫颈疾病中P16INK4a蛋白的表达 [J]. 昆明医科大学学报, 2015, 36(12): 134-8.

[4] 冯昊, 宋国慧, 杨娟, 郝长青, 王孟, 李变云, 赵德利, 刘志才, 魏文强, 乔友林. 中国农村食管癌高发区人群终生一次内镜筛查适宜年龄的卫生经济学评价 [J]. 中华肿瘤杂志, 2015, 37(06): 476-80.

[5] 李纪宾, 乔友林. 城市宫颈癌防治经验探索——深圳宫颈癌防治10年 [J]. 中国肿瘤, 2015, 24(12): 971-2.

[6] 李雨聪, 张莉, 胡尚英, 赵方辉, 乔友林, 李少林. 高危型人乳头瘤病毒检测初筛宫颈癌后几种分流方法的效果评价 [J]. 肿瘤, 2015, 35(05): 536-43.

[7] 马俊飞, 赵雪莲, 张莉, 向喜娥, 王素梅, 邱丽芝, 张倩, 胡尚英, 赵方辉. 2006—2009年山西省襄垣县VIA/VILI筛查宫颈癌的检出效果评价 [J]. 癌症进展, 2015, 13(06): 637-41.

[8] 乔友林. 适宜发展中国家与地区的宫颈癌快速筛查技术的研究及意义 [J]. 中华预防医学杂志, 2015, 49(02): 110-1.

[9] 乔友林, 于露露. 人乳头瘤病毒在子宫颈癌筛查中的意义和作用 [J]. 妇产与遗传(电子版), 2015, 5(03): 7-11.

[10] 乔友林, 赵宇倩. 宫颈癌的流行病学现状和预防 [J]. 中华妇幼临床医学杂志(电子版), 2015, 11(02): 1-6.

[11] 王孟, 乔友林. 终生一次内镜筛查降低食管癌累计发病率和死亡率 [J]. 循证医学, 2015, 15(04): 210.

[12] 王少明, 范金虎, 张雨晴, 杨召, 王国顺, 杨向华, 乔友林. 甲状腺肿可能增加胃癌的死亡风险——林县营养干预试验27年随访结果 [J]. 中国肿瘤, 2015, 24(06): 439-43.

[13] 魏文强, 乔友林. 食管癌预防医学的重要研究进展 [J]. 浙江医学, 2015, 37(10): 808.

[14] 严毅, 王晓辉, 王玉, 乔友林, 胡尚英. 甘肃武都农村妇女HPV感染、CIN病变与P16~(INK4A)表达相关性分析 [J]. 中华疾病控制杂志, 2015, 19(11): 1171-3.

[15] 于淮通, 范金虎. 2型糖尿病患者糖尿病防治知识认知程度调查分析及意义 [J]. 世界最新医学信息文摘, 2015, 15(53): 92 22.

[16] 于露露, 陈汶. 子宫颈癌筛查技术新进展 [J]. 中华妇产科杂志, 2015, 50(04): 312-5.

[17] 张柏林, 张倩, Sivasubramaniam P G, 高纪东, 方仪, 王翔, 张保宁, 张斌, 唐中华, 谢小明, 杨红建, 何建军, 李卉, 李佳圆, 范金虎, 乔友林. 中国年轻乳腺癌发病危险因素——多中心十年回顾性研究 [J]. 中国肿瘤, 2015, 24(12): 1042-7.

[18] 张欢欢, 王少明, 乔友林, 段仙芝. 人乳头瘤状病毒预防性疫苗研发现状及应用中存在的问题 [J]. 山东医药, 2015, 55(35): 97-9.

[19] 张永侠, 张彬, 周慧芳, 刘文胜, 陈汶, 徐震纲. 人乳头状瘤病毒相关扁桃体癌患者临床特征及p16和p53蛋白表达情况 [J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(02): 131-7.

[20] 张雨晴, 范金虎, 依荷芭丽·迟, 石素胜, 袁兴华, 蒋力明, 贺宇彤, 马莉, 孙喜斌, 陈原

[21] 赵宇倩, 宋艳, 赵方辉, 章文华, 李凌, 陈凤, 陈汶, 潘秦镜, 沈贵华, 乔友林. 阴道镜下四象限活检在宫颈癌前病变筛查中的价值 [J]. 中华肿瘤杂志, 2015, 37(11): 875-9.

[22] 赵宇倩, 赵方辉, 胡尚英, 陈汶, 陈凤, 崔剑锋, 刘彬, 章文华, 张询, 潘秦镜, 乔友林. 中国女性人群宫颈人乳头瘤病毒感染及型别分布的多中心横断面研究 [J]. 中华流行病学杂志, 2015, 36(12): 1351-6.

[23] 郑凤仙, 孙小伟, 李彩红, 高国旗, 赵宇倩, 赵方辉, 李晓莉, 张丽霞, 李长卿, 刘金红, 胡巧芝, 于爱敏. 河南省新密市2010~2013年农村女性宫颈癌筛查结果分析 [J]. 中国肿瘤, 2015, 24(12): 1007-11.

[24] 董丽, 乔友林. 宫颈腺癌与HPV [J]. 实用妇产科杂志, 2016, 32(08): 561-2.

[25] 何红艳, 王少明, 乔友林, 段仙芝. 几种人乳头瘤病毒检测方法的研究 [J]. 中外女性健康研究, 2016, 04): 12-3 5.

[26] 雷晓琴, 陈汶, 于露露, 吴泽妮, 秦宇, 高国旗, 郑凤仙, 李彩红, 练雪梅. 河南新密农村地区妇女生活方式、膳食因素与高危型HPV持续感染的关系研究 [J]. 卫生研究, 2016, 45(01): 45-50.

[27] 刘彬, 吴泽妮, 刘潇阳, 孙海魁, 李青, 林春青, 曾亮, 崔剑峰, 于晓红, 张询, 李凌, 陈汶. 人乳头瘤病毒与子宫颈腺癌病因关系研究 [J]. 中华肿瘤杂志, 2016, 38(04): 277-82.

[28] 刘妞, 胡尚英, 张倩, 刘远立, 乔友林. 全球子宫颈癌筛查指南析评 [J]. 癌症进展, 2016, 14(12): 1210-2.

[29] 刘文羽, 卫飞雪, 唐杰, 杨尚波, 高亚春, 王婷, 姜允飞, 李梅, 洪颖, 储凯, 陈汶, 胡月梅, 朱凤才. 江苏省阜宁地区自然人群中18～45岁女性人乳头瘤病毒16、18型中和抗体及DNA的流行率 [J]. 中华流行病学杂志, 2016, 37(03): 406-9.

[30] 乔友林. 食管癌流行病学研究的重要里程碑 [J]. 中国肿瘤临床, 2016, 43(12): 500-1.

[31] 苏采峰, 刘妞, 张倩, 向喜娥, 李志霞, 马俊飞, 史少东, 胡尚英, 赵方辉. 山西省襄垣县采用careHPV检测技术进行宫颈癌初筛的效果分析 [J]. 中国肿瘤, 2016, 25(08): 608-11.

[32] 孙小伟, 郑凤仙, 刘金红, 赵方辉, 张丽霞, 宋艳, 乔友林. 国产HPV杂交捕获技术在农村宫颈癌筛查中的应用 [J]. 中华肿瘤防治杂志, 2016, 23(03): 137-41.

[33] 孙小伟, 郑凤仙, 赵方辉, 刘金红, 王晶, 张倩, 钱金鹏, 胡巧枝, 于爱敏, 宋俊霞, 高银存, 牛彩霞, 李彩红. 两种方法筛查子宫颈癌的效果分析 [J]. 中国妇幼保健, 2016, 31(17): 3635-8.

[34] 吴泽妮, 陈汶. 人乳头瘤病毒自然史与空间分布特征对宫颈癌筛查技术的影响 [J]. 中华肿瘤杂志, 2016, 38(04): 241-5.

[35] 吴泽妮, 秦宇, 李婷媛, 姜明月, 刘彬, 于露露, 王红, 崔剑峰, 陈汶. 透景HPV检测试剂在高危HPV DNA检测及宫颈上皮内瘤变筛查中的应用 [J]. 临床检验杂志, 2016, 34(02): 90-4.

[36] 杨召, 王少明, 梁赫, 乔友林, 范金虎. 竞争风险型数据统计分析理论研究进展 [J]. 中国卫生统计, 2016, 33(06): 1088-91.

[37] 杨召, 王少明, 梁赫, 于佩, 范金虎, 乔友林. 新鲜水果摄入可能降低食管癌长期死亡风险 [J]. 中国肿瘤临床, 2016, 43(18): 808-13.

[38] 张保宁, 陈万青, 张希, 乔友林. 中国乳腺癌防控形势面临挑战 [J]. 中华肿瘤杂志, 2016, 38(10): 798-800.

[39] 张莉, 冯瑞梅, 胡尚英, 张倩, 赵雪莲, 热米拉·热扎克, 陈凤, 张询, 潘秦镜, 赵方辉, 乔友林. 细胞学检测为非典型鳞状细胞且人乳头瘤病毒阴性妇女的宫颈癌患病风险评估 [J]. 中华流行病学杂志, 2016, 37(06): 801-4.

[40] 张倩, 胡尚英, 冯瑞梅, 董丽, 陈凤, 张询, 潘秦镜, 马俊飞, 史少东, 赵方辉, 乔友林. 高危型人乳头瘤病毒感染变化与宫颈癌及癌前病变发病风险的15年前瞻队列随访研究 [J]. 中华肿瘤杂志, 2016, 38(10): 792-7.

[41] 张雨晴, 马莉, 贺宇彤, 孙丽华, 乔友林, 范金虎. 2001~2010年中国胰腺神经内分泌肿瘤的临床流行病学特征分析[J]. 中国肿瘤, 2016, 25(05): 329-33.

[42] 周清华, 范亚光, 王颖, 乔友林, 王贵齐, 黄云超, 王新允, 吴宁, 张国桢, 郑向鹏, 步宏. 中国肺部结节分类、诊断与治疗指南(2016年版) [J]. 中国肺癌杂志, 2016, 19(12): 793-8.

[43] 党乐, 马俊飞, 郭董平, 李八一, 苏采峰, 赵宇倩, 冯瑞梅, 张询, 潘秦镜, 胡尚英, 赵方辉, 乔友林. 我国农村地区宫颈癌筛查中人乳头瘤病毒检测阳性女性的分流策略 [J]. 中国肿瘤临床与康复, 2017, 24(03): 257-61.

[44] 董丽, 胡尚英, 张倩, 冯瑞梅, 张莉, 赵雪莲, 马俊飞, 史少东, 张询, 潘秦镜, 章文华, 乔友林, 赵方辉. 山西省宫颈癌筛查队列中人乳头瘤病毒基因型别分布10年动态变化规律研究 [J]. 中华流行病学杂志, 2017, 38(01): 20-5.

[45] 范振列, 杨召, 乔友林, 袁兴华. 109例直肠神经内分泌肿瘤患者的临床病理特征与预后分析 [J]. 中国肿瘤, 2017, 26(04): 308-14.

[46] 冯瑞梅, 陈汶, 乔友林. 高危型人乳头瘤病毒核酸体外检测试剂盒临床功能验证的中美指导原则解读 [J]. 中华肿瘤杂志, 2017, 39(07): 553-7.

[47] 管晨滔, 赵宏, 李新庆, 曲宸绪, 蔡建强, 魏文强, 乔友林. 肝细胞癌患者的基本特征及其生存分析 [J]. 中华肿瘤杂志, 2017, 39(03): 231-5.

[48] 何美, 杜佳, 赵方辉, 雷海科, 张艳, 李蓉, 周琦, 邱惠. 城市女性宫颈癌机会性筛查接受障碍原因及影响因素 [J]. 中国公共卫生, 2017, 33(08): 1166-9.

[49] 胡尚英, 热米拉·热扎克, 张倩, 董丽, 陈凤, 张询, 潘秦镜, 章文华, 马俊飞, 乔友林, 赵方辉. HPV16/18 DNA分型对宫颈细胞学ASC-US女性的风险分层管理作用研究 [J]. 肿瘤学杂志, 2017, 23(09): 780-4.

[50] 梁赫, 王少明, 杨召, 于佩, Taylor P R, Abnet C C, 范金虎, 乔友林. 新鲜水果可能降低男性吸烟人群中食管癌的长期死亡风险:林县营养干预试验30年随访研究 [J]. 中国肿瘤, 2017, 26(12): 953-9.

[51] 刘妞, 张希, 党乐, 何涛, 刘多丽, 高春翔, 常挨厚, 刘美清, 张红梅, 段仙芝, 乔友林, 刘远立. 内蒙古自治区鄂尔多斯市汉族和蒙古族女性乳腺癌筛查认知及意愿调查 [J]. 肿瘤研究与临床, 2017, 29(03): 191-6.

[52] 史少东, 贾萌萌, 王少明, 王莉, 李旭亮, 苏采峰, 石艳梅, 郝燕, 乔友林. 山西省襄垣县2009～2015年农村女性宫颈癌筛查项目结果分析 [J]. 中国肿瘤, 2017, 26(07): 536-9.

[53] 王海瑞, 廖光东, 陈汶, 乔友林, 江宇. p16/Ki-67免疫细胞化学双染在宫颈癌筛查中的应用价值 [J]. 中华肿瘤杂志, 2017, 39(08): 636-40.

[54] 王海瑞, 廖光东, 江宇, 李雨聪, 乔友林, 陈汶. p16/mcm2双染在宫颈上皮内瘤变的诊断价值及其与高危型HPV感染的关系 [J]. 中华流行病学杂志, 2017, 38(09): 1241-5.

[55] 王轶英, 王悦, 乔友林, 孔北华, Zheng W. 中国宫颈癌筛查未来之路——细胞学初筛的弃或守 [J]. 中国实用妇科与产科杂志, 2017, 33(03): 324-6.

[56] 魏丽惠, 赵昀, 沈丹华, 赵方辉, 耿力, 毕蕙, 徐海苗, 李静然. 中国子宫颈癌筛查及异常管理相关问题专家共识(一) [J]. 中国妇产科临床杂志, 2017, 18(02): 190-2.

[57] 吴昕, 赵骏, 崔雪莲, 李晴, 陶华, 潘秦镜, 张询, 陈汶, 李艳萍, 李荣成, 吴婷, 黎明强. 广西壮族自治区柳州市18～45岁社区女性人乳头瘤病毒感染及型别分布的横断面调查 [J]. 中华流行病学杂志, 2017, 38(04): 467-71.

[58] 闫宇, 任予, 范金虎, 张斌, 杨红建, 谢小明, 唐中华, 李卉, 李佳圆, 王淑莲, 乔友林, 何建军. 65岁以上中国老年女性原发性乳腺癌临床病理特征及治疗分析:多中心10年回顾性研究 [J]. 中国肿瘤, 2017, 26(07): 561-6.

[59] 张永侠, 刘明波, 黄辉, 陈汶, 张彬. 124例舌根鳞状细胞癌临床总结及预后分析 [J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(24): 1867-72.

[60] 赵方辉. 注射HPV疫苗利大于弊 [J]. 中国食品药品监管, 2017, (09): 76.

[61] 赵方辉, 张莉. 新时代下的肿瘤预防研究 [J]. 中华预防医学杂志, 2017, 51(08): 665-6.

[62] 赵骏, 吴昕, 崔雪莲, 李晴, 陶华, 潘秦镜, 张询, 陈汶, 李艳萍, 李荣成, 黄守杰, 吴婷, 黎明强. 广西柳州18～45岁女性人乳头瘤病毒16/18型中和抗体流行率及其与宫颈病变相关性的研究 [J]. 病毒学报, 2017, 33(03): 354-60.

[63] 郑凤仙, 孙小伟, 李彩红, 刘金红, 赵宇倩, 王晶, 钱金鹏, 乔友林. HPV检测技术初筛巴氏涂片分流应用于农村女性宫颈癌筛查效果 [J]. 中华疾病控制杂志, 2017, 21(05): 492-5 500.

[64] 富诗岚, 余艳琴, 徐慧芳, 胡尚英, 乔友林, 赵方辉. 中国大陆人群对人乳头瘤病毒预防性疫苗的认知和态度 [J]. 中国肿瘤临床, 2018, 45(23): 1220-4.

[65] 胡尚英, 乔友林. 2017年WHO HPV疫苗立场文件的解读 [J]. 中华预防医学杂志, 2018, 52(05): 464-8

[66] 陈汶. 接种疫苗与筛查并重 [N]. 中国科学报,2018-05-18(008).

[67] 姜明月, 冯瑞梅, 王林, 李婷媛, 张爱爱, 崔剑锋, 潘秦镜, 张询, 刘美丽, 高峰, 陈汶, 乔友林. 液基细胞学联合人乳头状瘤病毒核酸检测对宫颈癌筛查的效果评价 [J]. 中华肿瘤杂志, 2018, 40(10): 750-6.

[68] 李菊晓, 董丽, 李莉, 陈汶. 高危型人乳头状瘤病毒感染人群分流方法的研究进展 [J]. 中华肿瘤杂志, 2018, 40(09): 641-6.

[69] 李莉, 陈汶, 杨欢, 朱琳. HPV检测技术在宫颈癌中的研究进展 [J]. 癌症进展, 2018, 16(03): 278-81.

[70] 李莉, 王林, 李菊晓, 李志芳, 乔友林, 陈汶, 朱琳. 宫颈细胞内p16/Ki67表达与宫颈癌及癌前病变的关系及其用于HPV阳性人群分流的诊断价值 [J]. 中国肿瘤, 2018, 27(04): 311-5.

[71] 李莉, 王林, 李志芳, 李婷媛, 乔友林, 朱琳, 陈汶. Aptima HPV E6/E7mRNA技术检出宫颈癌及癌前病变的临床效果研究 [J]. 中国妇产科临床杂志, 2018, 19(04): 341-4.

[72] 李婷媛, 吴泽妮, 姜明月, 崔剑峰, 刘彬, 陈凤, 陈汶. 不同感染状态下高危型人乳头状瘤病毒载量与子宫颈病变发生的关系 [J]. 中华肿瘤杂志, 2018, 40(06): 475-80.

[73] 林威, 刘植华, 王月云, 富诗岚, 袁世新, 陈斌, 吴波, 乔友林. 深圳女性子宫颈人乳头瘤病毒感染型别分布情况 [J]. 中国热带医学, 2018, 18(11): 1088-90 94.

[74] 刘植华, 林威, 王月云, 吴波, 袁世新, 姚吉龙, 赵晓山, 陈斌, 乔友林, 赵方辉, 陈汶, 胡尚英. 高危型人乳头状瘤病毒风险分层在深圳地区人乳头状瘤病毒初筛阳性人群分流中的应用 [J]. 中华肿瘤杂志, 2018, 40(10): 757-63.

[75] 杨欢,陈志权,范金虎.森林医学发展历程和前景及其对疾病的预防作用[J].世界林业研究,2019,32(04):29-33

[76] 乔友林. 中国宫颈癌防治任重而道远 [J]. 中华肿瘤杂志, 2018, 40(10): 721-3.

[77] 热米拉·热扎克, 朱之恺, 张倩, 徐小倩, 韦梦娜, 胡尚英, 王岩, 张莉, 赵雪莲, 乔友林, 赵方辉. 不同介质标本中人乳头瘤病毒E6癌蛋白检测效果对比研究 [J]. 病毒学报, 2018, 34(05): 549-54.

[78] 陶思源, 彭介入, 王英, 张桂婷, 陈志余, 赵霏, 马剑桥, 杨雪, 乔友林, 赵方辉, 杨春霞. 子宫颈癌及癌前病变患者直接经济负担及其影响因素研究 [J]. 中华预防医学杂志, 2018, 52(12): 1281-6.

[79] 王林, 姜明月, 曹雪芳, 李莉, 秦宇, 吴泽妮, 李婷媛, 吴婷, 陈汶. 恒温扩增HPV检测技术应用于子宫颈癌筛查的效果评价研究 [J]. 病毒学报, 2018, 34(04): 498-504.

[80] 王林, 姜明月, 秦宇, 李莉, 吴泽妮, 李婷媛, 吴婷, 陈汶. 人乳头状瘤病毒DNA恒温扩增技术在宫颈癌筛查中的应用价值 [J]. 中华肿瘤杂志, 2018, 40(04): 313-8.

[81] 王月云, 林威, 吴波, 袁世新, 姚吉龙, 赵晓山, 陈斌, 乔友林, 赵方辉, 陈汶, 胡尚英, 刘植华. 2014—2016年深圳市子宫颈癌筛查中HPV阳性者HPV高危亚型分布及相关因素 [J]. 中华预防医学杂志, 2018, 52(05): 480-5.

[82] 王月云, 唐朝, 刘植华, 林威, 袁世新, 陈斌, 吴波, 乔友林. 深圳市女性子宫颈人乳头瘤病毒感染危险因素分析 [J]. 中国热带医学, 2018, 18(11): 1083-7.

[83] 魏丽惠, 乔友林. 《预防子宫颈癌百问百答》 [J]. 出版参考, 2018, (10): 2.

[84] 吴泽妮, 苏征, 陈汶, 乔友林. 人乳头状瘤病毒检测在28 923例不能明确意义的不典型鳞状细胞患者中的应用:中国104项研究汇总分析 [J]. 中华病理学杂志, 2018, 47(04): 269-73.

[85] 徐小倩, 张莉, 胡尚英, 热米拉·热扎克, 赵雪莲, 陈凤, 张询, 潘秦镜, 乔友林, 赵方辉. HPV载量在阴道镜下随机活检中的作用分析 [J]. 中华预防医学杂志, 2018, 52(05): 475-9.

[86] 薛鹏, 乔友林, 江宇. 人工智能在医学内窥镜诊断中的应用 [J]. 中华肿瘤杂志, 2018, 40(12): 890-3.

[87] 余艳琴, 贾萌萌, 郝金奇, 富诗岚, 徐慧芳, 赵方辉, 胡尚英, 范金虎, 乔友林. 中国女性三阴性乳腺癌发病相关因素的Meta分析 [J]. 中国肿瘤, 2018, 27(11): 881-8.

[88] 余艳琴, 乔友林. 中国HPV预防性疫苗防治宫颈癌的应用前景 [J]. 肿瘤预防与治疗, 2018, 31(04): 237-41.

[89] 张爱爱, 党乐, 何涛, 刘多丽, 高春翔, 常挨厚, 刘美清, 张红梅, 段仙芝, 张莉, 赵方辉, 乔友林. 汉族和蒙古族女性宫颈癌筛查认知意愿和疫苗接受度调查 [J]. 中国肿瘤临床与康复, 2018, 25(10): 1153-8.

[90] 张莉, 李佳瑶, 热米拉·热扎克, 胡尚英, 徐小倩, 赵雪莲, 赵爽, 胡芳芳, 陈凤, 张询, 乔友林, 赵方辉. hrHPV DNA载量 分型和E6蛋白对宫颈癌前病变进展的预测作用 [J]. 中国肿瘤临床, 2018, 45(17): 878-82.

[91] 张莉, 热米拉·热扎克, 胡尚英, 赵雪莲, 徐小倩, 富诗岚, 马俊飞, 任红梅, 赵方辉. 山西省襄垣县农村妇女和基层医务人员对宫颈癌及其筛查的认知和评价 [J]. 中国妇幼卫生杂志, 2018, 9(02): 1-5 9.

[92] 张莉, 赵方辉. 预防性人乳头状瘤病毒疫苗的应用研究进展 [J]. 中华肿瘤杂志, 2018, 40(10): 724-8.

[93] 赵静, 陈汶, 刘植华, 王月云, 龚林, 吴波. 常见阴道微生态异常与高危型HPV感染及子宫颈癌相关性研究进展 [J]. 中国热带医学, 2018, 18(11): 1099-102.

[94] 赵静, 李芹, 曹雪芳, 苑丹丹, 张旭梅, 柳露, 陈汶, 董丽, 阴建, 刘植华, 王月云, 乔友林, 江宇. 云南新平县女性阴道微生态异常与HR-HPV的相关性研究 [J]. 中国热带医学, 2018, 18(12): 1222-5.

[95] 赵爽, 赵方辉. HPV治疗性疫苗研究进展 [J]. 中华预防医学杂志, 2018, 52(05): 556-60.

[96] 赵雪莲, 热米拉·热扎克, 胡尚英, 张莉, 徐小倩, 陈凤, 潘秦镜, 张询, 赵方辉. 高危型HPV DNA单独检测及与薄层液基细胞学联合筛查对宫颈癌及宫颈高度病变的筛查效果比较 [J]. 中华预防医学杂志, 2018, 52(05): 469-74.

[97] 赵宇倩, 戴毅, 党乐, 孔令华, 张颖, 冯瑞梅, 乔友林, 郎景和. 适合中国人群的宫颈癌筛查技术和效果评价的真实世界研究 [J]. 中华肿瘤杂志, 2018, 40(10): 764-71.

[98] 周清华, 范亚光, 王颖, 乔友林, 王贵齐, 黄云超, 王新允, 吴宁, 张国桢, 郑向鹏, 步宏, 李印, 韦森, 陈良安, 胡成平, 石远凯, 孙燕. 中国肺癌低剂量螺旋CT筛查指南(2018年版) [J]. 中国肺癌杂志, 2018, 21(02): 67-75.

[99] 冯萍, 范金虎, 周彩红. 患者表扬渠道维护和优化分析 [J]. 中国医学人文, 2019, 5(06): 15-8.

[100] 冯萍, 杨欢, 范金虎, 周彩虹. 患者表扬与医务人员激励机制研究 [J]. 中国肿瘤临床与康复, 2019, 26(06): 675-9.

[101] 李琤, 范金虎, 付凤环. 中国医学科学院肿瘤医院加强青年职工廉政管理的调查研究 [J]. 中国医院, 2019, 23(12): 46-8.

[102] 梁青壮, 韦伟, 陈汶, 黄辉, 邹霜梅, 林青春, 乔友林, 徐震纲, 吴跃煌. 鼻腔鼻窦内翻性乳头状瘤恶变鳞状细胞癌中HPV的分布及预后分析 [J]. 中国耳鼻咽喉颅底外科杂志, 2019, 25(02): 172-6.

[103] 柳安琪, 陈汶. 食管微生物与食管相关疾病研究进展 [J]. 中华肿瘤杂志, 2019, (08): 561-4.

[104] 柳安琪, 邵丹彤, 苏征, 刘雨菁, 魏文强, 陈汶. 贲门癌患者口腔菌群的分布特征 [J]. 基础医学与临床, 2019, 39(05): 710-3.

[105] 卢宪中, 茅艺伟, 乔友林, 陈文. 宫颈癌公共筛查策略的经济学评价 [J]. 中国药物经济学, 2019, 14(03): 5-10.

[106] 彭介入, 陶思源, 温莹, 杨雪, 马剑桥, 赵霏, 陈志余, 张桂婷, 乔友林, 赵方辉, 杨春霞. 中国城镇地区子宫颈癌筛查的卫生经济学评价 [J]. 中华肿瘤杂志, 2019, (02): 154-60.

[107] 乔友林, 赵方辉. 首个国产子宫颈癌疫苗获批上市，售价仅为同种进口疫苗的一半 [J]. 抗癌之窗, 2019, (06): 6-7.

[108] 沈洁, 韩历丽, 张月, 高丽丽, 陈汶, 张瑞, 薛鹏, 张妍. 高危型人乳头瘤病毒检测用于子宫颈癌筛查的评估分析 [J]. 中国妇产科临床杂志, 2019, 20(02): 146-8.

[109] 王华庆, 王岩, 王朝华, 王亚敏, 孙晓冬, 许涤沙, 李明珠, 李燕, 李智, 余文周, 余艳琴, 岳晨妍, 张小松, 郭欣, 胡尚英, 赵方辉, 赵超, 赵昀, 秦冉, 夏昌发. 子宫颈癌等人乳头瘤病毒相关疾病免疫预防专家共识（简版） [J]. 中国疫苗和免疫, 2019, 25(06): 718-35.

[110] 王鹏, 郭珍, 赵冬梅, 贾漫漫, 陈琼, 吴泽妮, 郭沛沛, 陈佩佩, 徐慧芳, 郑黎阳, 孙喜斌, 乔友林, 张韶凯. 高危型人乳头瘤病毒E6/E7 mRNA对未明确意义的非典型鳞状上皮细胞人群分流的意义 [J]. 中国肿瘤, 2019, 28(11): 876-82.

[111] 王玉莹, 王兆京, 张瑜, 高晓虹, 杨春霞, 赵方辉, 乔友林, 马莉, 郎景和. 中国农村15种子宫颈癌筛查方案的卫生经济学评价 [J]. 中华妇产科杂志, 2019, (12): 840-847.

[112] 徐慧芳, 乔友林. 尿液HPV检测的研究进展 [J]. 中国肿瘤, 2019, 28(09): 705-9.

[113] 薛鹏, 沈洁, 李莉, 赵静, 陈汶, 乔友林, 江宇. HPV E6/E7 mRNA和HPV DNA检测技术在宫颈上皮内瘤变中的诊断价值分析 [J]. 癌症进展, 2019, 17(10): 1160-3 77.

[114] 薛鹏, 唐朝, 乔友林, 江宇. 人工智能电子阴道镜辅助诊断系统对宫颈癌筛查的现实挑战和未来机遇 [J]. 中国肿瘤, 2019, 28(07): 483-6.

[115] 于佩, 梁赫, 易宗毕, 张粟, 江泽飞, 佟仲生, 王佳玉, 范金虎, 乔友林, 徐兵河. 影响中国华北地区女性乳腺癌无病生存期的临床病理因素——多中心回顾性研究 [J]. 中国肿瘤, 2019, 28(04): 315-20.

[116] 余艳琴, 富诗岚, 徐慧芳, 韦梦娜, 陈琦, 胡尚英, 赵方辉, 乔友林. 中国大陆女性体检人群中人乳头瘤病毒型别感染率及九价疫苗中HPV各型别分布的系统评价 [J]. 肿瘤预防与治疗, 2019, 32(02): 103-13.

[117] 余艳琴, 乔友林. 人群肿瘤环境危险因素归因危险度概述 [J]. 现代预防医学, 2019, 46(01): 162-5 75.

[118] 张莉, 热米拉·热扎克, 胡尚英, 董丽, 赵爽, 赵雪莲, 徐小倩, 潘秦镜, 张询, 乔友林, 赵方辉. 阴道镜结果正常或低度病变妇女发生宫颈癌前病变的前瞻性风险分层研究 [J]. 中国肿瘤临床, 2019, 46(15): 768-72.

[119] 张永侠, 刘明波, 黄辉, 陈汶, 张彬. 第七版与第八版美国癌症联合会TNM分期对口咽癌预后生存的分析比较 [J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(07): 586-90.

[120] 赵方辉, 张莉. 预防性人类乳头瘤病毒疫苗开启了宫颈癌的全面防控时代 [J]. 中华预防医学杂志, 2019, (01): 10-2.

[121] 赵爽, 赵雪莲, 胡尚英, 王岩, 热米拉·热扎克, 徐小倩, 段仙芝, 陈凤, 张询, 赵方辉. 汉族和蒙古族女性HPV感染率及型别分布的差异分析 [J]. 中华流行病学杂志, 2019, (11): 1439-44.

[122] 罗贤懋, 林培中, 刘雨菁, 乔友林. 核黄素预防恶性肿瘤的研究进展 [J]. 癌症进展, 2020, 18(04): 325-30.

[123] 王鹏, 郭珍, 赵冬梅, 徐慧芳, 贾漫漫, 任玲艳, 陈佩佩, 孙星媛, 李梦洁, 孙喜斌, 乔友林, 张韶凯. 高危型HPV分型检测对早期宫颈癌诊断的意义 [J]. 中华医学杂志, 2020, (18): 1396-400.

[124] 韦梦娜, 余艳琴, 徐慧芳, 富诗岚, 胡尚英, 赵方辉, 乔友林. 中国大陆地区不同宫颈病变人群中人乳头瘤病毒感染率及型别分布的系统研究 [J]. 中国肿瘤临床与康复, 2020, 27(02): 133-7.

[125] 魏丽惠, 谢幸, 刘继红, 赵昀, 陈汶, 李静然, 赵超, 王少明, 李明珠. 四价人乳头瘤病毒疫苗预防中国大陆女性HPV持续感染及下生殖道相关疾病的保护效力:一项随访78个月的随机对照研究 [J]. 中国妇产科临床杂志, 2020, 21(02): 158-62.

[126] 徐慧芳, 余艳琴, 邵晨轶, 张询, 胡尚英, 赵方辉, 乔友林. DH3与cobas4800在宫颈癌筛查中的效果对比研究 [J]. 中国肿瘤临床与康复, 2020, 27(02): 129-32.

[127] 薛鹏, 沈洁, 韩历丽, 江宇, 陈汶, 乔友林. 国内人乳头瘤病毒检测技术在不同实验室间的重复性评价研究 [J]. 癌症进展, 2020, 18(05): 456-8 74.

[128] 闫慧姣, 乔友林. HPV疫苗和筛查：人类癌症防治的典范 [J]. 抗癌之窗, 2020, (02): 10-1.

[129] 余艳琴, 郝金奇, 徐慧芳, 韦梦娜, 乔友林. 宫颈癌综合预防和控制的应用和前景 [J]. 中国医学科学院学报, 2020, 42(04): 535-9.

[130] 余艳琴, 徐慧芳, 郝金奇, 乔友林. 医学人工智能引发的相关伦理问题分析 [J]. 中国医学科学院学报, 2020, 42(01): 128-31.

[131] 张韶凯, 罗喜平, 李志芳, 苏征, 夏继超, 胡桂英, 朱玉静, 谢龙旭, 冯向先, 孙喜斌, 陈汶, 乔友林. 人乳头瘤病毒分型检测在宫颈癌前病变和宫颈癌筛查中的应用价值 [J]. 中华肿瘤杂志, 2020, 03): 252-6.

[132] 张韶凯, 赵方辉, 乔友林. 中国宫颈癌防治研究20年历程与成就 [J]. 中华流行病学杂志, 2020, 41(06): 809-12.

[133] 张粟, 杨欢, 王国清, 范金虎, 乔友林. 河南省林州市食管鳞癌及癌前病变的影响因素研究 [J]. 中国肿瘤, 2020, 29(05): 327-33.

[134] 周静, 玛依努尔·尼亚孜, 周琦, 王平, 陈汶, 李静, 玛依努尔·尼亚孜. 我国西部地区宫颈癌患者HPV感染现状及影响因素分析 [J]. 中国妇产科临床杂志, 2020, 21(01): 13-6.

三、会议论文：

[1] 胡尚英,冯瑞梅,赵方辉,陈凤,乔友林. 主动、被动吸烟与人乳头瘤病毒感染和宫颈高度癌前病变的关系:一项多中心以人群为基础的横断面研究[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[2] 张倩,冯瑞梅,胡尚英,马俊飞,陈凤,李志霞,赵方辉,乔友林. 山西宫颈癌筛查队列妇女高危HPV感染率的15年变化分析[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[3] 孙小伟,赵方辉,赵宇倩,李彩红,郑凤仙,李晓莉,张丽霞,刘金红,乔友林. 国产HPV核酸检测(DH2)在农村地区宫颈癌筛查中的应用[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[4] 赵雪莲,马俊飞,张莉,向喜娥,王素梅,邱丽芝,张倩,胡尚英,赵方辉. 2006-2009年山西省襄垣县VIA/VILI筛查宫颈癌的临床效果评价[A]. 中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[5] 赵宇倩,陈凤,赵方辉,胡尚英,张询,郑凤仙,乔友林. careHPV在农村基层应用的可行性研究[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[6] 张莉,冯瑞梅,胡尚英,张倩,赵雪莲,热米拉.热扎克,陈凤,张询,潘秦镜,赵方辉,乔友林. 宫颈癌筛查轻度异常妇女的患病风险评价[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[7] 张雨晴,范金虎,依荷芭丽·迟,石素胜,袁兴华,蒋力明,贺宇彤,马莉,孙喜斌,陈原稼,乔友林. 胃肠胰腺神经内分泌肿瘤全国多中心10年回顾性临床流行病学研究[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[8] 王少明,范金虎,杨召,张雨晴,乔友林. 补充硒、维生素E和β-胡萝卜素对降低人群上消化道癌症死亡率可能有长期持续效益:林县营养干预试验27年随访结果[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[9] 任建松,Gwen Murphy,范金虎,Sanford Dawsey,Philip Taylor,Jacob Selhub,乔友林,Christian Abnet. 血清B族维生素与食管癌和胃贲门癌发病风险关系的前瞻性研究[A]. 中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[10] 杨召,王建炳,王少明,范金虎,乔友林. 口腔粘膜白斑可能增加食管癌长期死亡风险:林县营养干预试验28年随访结果[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.

[11] 范金虎,王建炳,Sanford M Dawsey,Rashmi Sinha,Neal D Freedman,Philip R Taylor,乔友林,Christian C Abnet. 饮食成分与总死亡,总癌症死亡,心血管疾病死亡风险之间关系研究——中国林县营养干预试验队列研究结果[A].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会.全国肿瘤流行病学和肿瘤病因学学术会议论文集[C].中国抗癌协会肿瘤病因学专业委员会、中国抗癌协会肿瘤流行病学专业委员会、中华医学会中华预防医学杂志编委会:中国抗癌协会,2015:1.